Hims & Hers Health is trading 3.53% lower at €25.70, with no clear company-specific catalyst identified for the October 1, 2026 move. - Healthcare-sector weakness may have contributed: XLV was down 1.33% during the regular session. - Reuters reported the U.S. 10-year Treasury yield reached 5.306%, its highest since mid-2007, adding to broader market pressure. - The October 1 newsroom featured leadership, not a material business announcement; no direct company-specific catalyst was established.